We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.5%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$228B
AUM Growth
+$29.9B
Cap. Flow
+$21.5B
Cap. Flow %
9.45%
Top 10 Hldgs %
22.25%
Holding
10,525
New
1,702
Increased
3,804
Reduced
3,457
Closed
1,419

Sector Composition

Rank Sector Weight
1 Technology 2.03%
2 Consumer Discretionary 1.46%
3 Financials 1.01%
4 Healthcare 0.92%
5 Communication Services 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORIG
9051
PUT
DELISTED
Ocean Rig UDW Inc. Class A Common Shares
ORIG
$8K ﹤0.01%
6
-28
-82% -$55.1K
ARGS
9052
PUT
DELISTED
Argos Therapeutics, Inc.
ARGS
$8K ﹤0.01%
1,110
-750
-40% -$6.39K
CDMO
9053
CALL
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$7K ﹤0.01%
1,671
-1,572
-48% -$6.43K
NSPRZ
9054
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$7K ﹤0.01%
+93,748
New +$12.2K
EVAR
9055
DELISTED
Lombard Medical, Inc.
EVAR
$7K ﹤0.01%
13,012
-9,774
-43% -$5.09K
TVIA
9056
CALL
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$7K ﹤0.01%
32,000
+3,800
+13% +$1.37K
CPHI icon
9057
China Pharma Holdings
CPHI
$37.6M
$6K ﹤0.01%
51
+28
+122% +$3.17K
KBLMR
9058
DELISTED
KBL Merger Corp. IV Rights expiring 11/9/2020
KBLMR
$6K ﹤0.01%
+15,965
New +$5.82K
TRX icon
9059
TRX Gold Corp
TRX
$403M
$5K ﹤0.01%
+10,251
New +$4.97K
C.WS.A
9060
DELISTED
Citigroup Inc
C.WS.A
$5K ﹤0.01%
31,250
-49,722
-61% -$6.2K
KODK.WS.A
9061
DELISTED
Eastman Kodak Company
KODK.WS.A
$4K ﹤0.01%
12,463
-1,560
-11% -$856
ONSIW
9062
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$3K ﹤0.01%
+16,332
New +$8.06K
NXTDW
9063
DELISTED
Nxt-ID, Inc.
NXTDW
$2K ﹤0.01%
+10,549
New +$1.65K
IMUC.WS
9064
DELISTED
ImmunoCellular Therapeutics Ltd.
IMUC.WS
$2K ﹤0.01%
93,737
LMFAW
9065
DELISTED
LM Funding America, Inc. Warrant
LMFAW
$1K ﹤0.01%
+10,805
New +$1.84K
EYEGW
9066
DELISTED
Eyegate Pharmaceuticals, Inc. Warrants
EYEGW
$1K ﹤0.01%
12,900
AAP icon
9067
Advance Auto Parts
AAP
$2.63B
-42,367
Closed -$5.82M
AAXJ icon
9068
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.87B
-84,081
Closed -$5.52M
ABM icon
9069
CALL
ABM Industries
ABM
$2.73B
-7,000
Closed -$305K
ACHC icon
9070
Acadia Healthcare
ACHC
$2.78B
-43,672
Closed -$1.93M
ACRS icon
9071
Aclaris Therapeutics
ACRS
$962M
-33,793
Closed -$1.01M
ACWI icon
9072
iShares MSCI ACWI ETF
ACWI
$33.3B
-517,782
Closed -$33.6M
ACWV icon
9073
CALL
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.41B
-3,000
Closed -$231K
ACWX icon
9074
iShares MSCI ACWI ex US ETF
ACWX
$12.6B
-14,341
Closed -$626K
AEG icon
9075
Aegon
AEG
$13.7B
-55,117
Closed -$218K

Similar funds

Jeff Yass's Q2 2017 Portfolio in Review

As of Q2 2017, Jeff Yass held 10,525 positions worth $228B, up 15% from $198B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Jeff Yass deployed $21.5B of net new capital in Q2 2017, opening 1,702 new positions and adding to 3,804 existing holdings. Its largest new stake was Altaba Inc: 9,835,232 shares worth $536M.

By sector, the portfolio is most concentrated in Technology at 2% of assets, up from 1.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $353M trimmed.

  • Jeff Yass's largest Q2 2017 buy was Altaba Inc: 9,835,232 shares worth $536M.
  • Jeff Yass added most to Apple in Q2 2017, an estimated $781M increase.
  • Jeff Yass's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $353M.
  • Jeff Yass fully exited Alphabet (Google) Class C in Q2 2017, selling an estimated $261M.
  • Jeff Yass's ten largest holdings make up 22% of its $228B portfolio in Q2 2017.
  • Jeff Yass opened 1,702 new positions and closed 1,419 in Q2 2017.
  • Jeff Yass's portfolio value rose 15% quarter-over-quarter to $228B.

Based on Susquehanna International Group's 13F filing for Q2 2017, filed 15 Aug 2017.